Showing results (11-20 of 159) with videos related to
Sort By:
Pageof 16
Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Small Molecules for PsoriasisCraig L LeonardiSeminars in Cutaneous Medicine and Surgery|August 24, 2016
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L LeonardiSeminars in Cutaneous Medicine and Surgery|June 1, 2018
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L LeonardiManaged Care (Langhorne, Pa.)|June 21, 2008
Overview of psoriasis: update on current and emerging treatment optionsCraig L LeonardiSeminars in Cutaneous Medicine and Surgery|October 1, 2014
Data on the safety of psoriasis therapiesCraig L LeonardiJournal of the American Academy of Dermatology|August 2, 2003
Efalizumab: an overviewCraig L LeonardiSeminars in Cutaneous Medicine and Surgery|August 16, 2016
New Therapies for PsoriasisCraig L LeonardiLancet (London, England)|May 20, 2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)Craig L Leonardi, Alexa B Kimball, Kim A Papp, et al.The Journal of Dermatological Treatment|December 7, 2007
Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasisDennis A Revicki, Mary Kaye Willian, Alan Menter, et al.Pageof 16